Cargando…

Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain

Others have analysed the relationship between inadequate behaviour by healthcare professionals in the diagnosis of dyslipidaemia (diagnostic inertia) and the history of cardiovascular risk factors. However, since no study has assessed cardiovascular risk scores as associated factors, we carried out...

Descripción completa

Detalles Bibliográficos
Autores principales: Palazón-Bru, Antonio, Sepehri, Armina, Ramírez-Prado, Dolores, Navarro-Cremades, Felipe, Cortés, Ernesto, Rizo-Baeza, Mercedes, Gil-Guillén, Vicente Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525685/
https://www.ncbi.nlm.nih.gov/pubmed/26246966
http://dx.doi.org/10.7717/peerj.1109
_version_ 1782384346084147200
author Palazón-Bru, Antonio
Sepehri, Armina
Ramírez-Prado, Dolores
Navarro-Cremades, Felipe
Cortés, Ernesto
Rizo-Baeza, Mercedes
Gil-Guillén, Vicente Francisco
author_facet Palazón-Bru, Antonio
Sepehri, Armina
Ramírez-Prado, Dolores
Navarro-Cremades, Felipe
Cortés, Ernesto
Rizo-Baeza, Mercedes
Gil-Guillén, Vicente Francisco
author_sort Palazón-Bru, Antonio
collection PubMed
description Others have analysed the relationship between inadequate behaviour by healthcare professionals in the diagnosis of dyslipidaemia (diagnostic inertia) and the history of cardiovascular risk factors. However, since no study has assessed cardiovascular risk scores as associated factors, we carried out a study to quantify diagnostic inertia in dyslipidaemia and to determine if cardiovascular risk scores are associated with this inertia. In the Valencian Community (Spain), a preventive programme (cardiovascular, gynaecologic and vaccination) was started in 2003 inviting persons aged ≥40 years to undergo a health check-up at their health centre. This cross-sectional study examined persons with no known dyslipidaemia seen during the first six months of the programme (n = 16, 905) but whose total cholesterol (TC) was ≥5.17 mmol/L. Diagnostic inertia was defined as lack of follow-up to confirm/discard the dyslipidaemia diagnosis. Other variables included in the analysis were gender, history of cardiovascular risk factors/cardiovascular disease, counselling (diet/exercise), body mass index (BMI), age, blood pressure, fasting blood glucose and lipids. TC was grouped as ≥/<6.20 mmol/L. In patients without cardiovascular disease and <75/≤65 years (n = 15, 778/13, 597), the REGICOR (REgistre GIroní del COr)/SCORE (Systematic COronary Risk Evaluation) cardiovascular risk functions were used to classify risk (high/low). Inertia was quantified and the adjusted odds ratios calculated from multivariate models. In the overall sample, the rate of diagnostic inertia was 52% (95% CI [51.2–52.7]); associated factors were TC ≥ 6.20 mmol/L, high or “not measured” BMI, hypertension, smoking and higher values of fasting blood glucose, systolic blood pressure and TC. In the REGICOR sample, the rate of diagnostic inertia was 51.9% (95% CI [51.1–52.7]); associated factors were REGICOR high and high or “not measured” BMI. In the SCORE sample the rate of diagnostic inertia was 51.7% (95% CI [50.9–52.5]); associated factors were SCORE high and high or “not measured” BMI. Diagnostic inertia existed in over half the patients and was associated with a greater cardiovascular risk.
format Online
Article
Text
id pubmed-4525685
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-45256852015-08-05 Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain Palazón-Bru, Antonio Sepehri, Armina Ramírez-Prado, Dolores Navarro-Cremades, Felipe Cortés, Ernesto Rizo-Baeza, Mercedes Gil-Guillén, Vicente Francisco PeerJ Diabetes and Endocrinology Others have analysed the relationship between inadequate behaviour by healthcare professionals in the diagnosis of dyslipidaemia (diagnostic inertia) and the history of cardiovascular risk factors. However, since no study has assessed cardiovascular risk scores as associated factors, we carried out a study to quantify diagnostic inertia in dyslipidaemia and to determine if cardiovascular risk scores are associated with this inertia. In the Valencian Community (Spain), a preventive programme (cardiovascular, gynaecologic and vaccination) was started in 2003 inviting persons aged ≥40 years to undergo a health check-up at their health centre. This cross-sectional study examined persons with no known dyslipidaemia seen during the first six months of the programme (n = 16, 905) but whose total cholesterol (TC) was ≥5.17 mmol/L. Diagnostic inertia was defined as lack of follow-up to confirm/discard the dyslipidaemia diagnosis. Other variables included in the analysis were gender, history of cardiovascular risk factors/cardiovascular disease, counselling (diet/exercise), body mass index (BMI), age, blood pressure, fasting blood glucose and lipids. TC was grouped as ≥/<6.20 mmol/L. In patients without cardiovascular disease and <75/≤65 years (n = 15, 778/13, 597), the REGICOR (REgistre GIroní del COr)/SCORE (Systematic COronary Risk Evaluation) cardiovascular risk functions were used to classify risk (high/low). Inertia was quantified and the adjusted odds ratios calculated from multivariate models. In the overall sample, the rate of diagnostic inertia was 52% (95% CI [51.2–52.7]); associated factors were TC ≥ 6.20 mmol/L, high or “not measured” BMI, hypertension, smoking and higher values of fasting blood glucose, systolic blood pressure and TC. In the REGICOR sample, the rate of diagnostic inertia was 51.9% (95% CI [51.1–52.7]); associated factors were REGICOR high and high or “not measured” BMI. In the SCORE sample the rate of diagnostic inertia was 51.7% (95% CI [50.9–52.5]); associated factors were SCORE high and high or “not measured” BMI. Diagnostic inertia existed in over half the patients and was associated with a greater cardiovascular risk. PeerJ Inc. 2015-07-28 /pmc/articles/PMC4525685/ /pubmed/26246966 http://dx.doi.org/10.7717/peerj.1109 Text en © 2015 Palazón-Bru et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Diabetes and Endocrinology
Palazón-Bru, Antonio
Sepehri, Armina
Ramírez-Prado, Dolores
Navarro-Cremades, Felipe
Cortés, Ernesto
Rizo-Baeza, Mercedes
Gil-Guillén, Vicente Francisco
Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain
title Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain
title_full Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain
title_fullStr Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain
title_full_unstemmed Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain
title_short Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain
title_sort diagnostic inertia in dyslipidaemia: results of a preventative programme in spain
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525685/
https://www.ncbi.nlm.nih.gov/pubmed/26246966
http://dx.doi.org/10.7717/peerj.1109
work_keys_str_mv AT palazonbruantonio diagnosticinertiaindyslipidaemiaresultsofapreventativeprogrammeinspain
AT sepehriarmina diagnosticinertiaindyslipidaemiaresultsofapreventativeprogrammeinspain
AT ramirezpradodolores diagnosticinertiaindyslipidaemiaresultsofapreventativeprogrammeinspain
AT navarrocremadesfelipe diagnosticinertiaindyslipidaemiaresultsofapreventativeprogrammeinspain
AT cortesernesto diagnosticinertiaindyslipidaemiaresultsofapreventativeprogrammeinspain
AT rizobaezamercedes diagnosticinertiaindyslipidaemiaresultsofapreventativeprogrammeinspain
AT gilguillenvicentefrancisco diagnosticinertiaindyslipidaemiaresultsofapreventativeprogrammeinspain